Search

Search Constraints

You searched for: Author/Creator Cappellini, M. Domenica

Search Results

1. Approaching low liver iron burden in chelated patients with non‐transfusion‐dependent thalassemia: the safety profile of deferasirox. (25th March 2014)

2. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. Issue 6 (June 2021)

3. Deferasirox demonstrates a dose‐dependent reduction in liver iron concentration and consistent efficacy across subgroups of non‐transfusion‐dependent thalassemia patients. Issue 6 (13th May 2013)

6. Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development. Issue 7 (3rd July 2021)